P

Inventor

SENGUPTA SAUMITRA

IN12 patents
⚠️ This page may combine multiple inventors who share the name “SENGUPTA SAUMITRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASANA BIOSCIENCES LLC

4 patents
US9499495B2Nov 22, 2016

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC4 citations80
US10912779B2Feb 9, 2021

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations59
US9757382B2Sep 12, 2017

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations48
US10226468B2Mar 12, 2019

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations47

BOCK MARK GARY

3 patents
US9029399B2May 12, 2015

17α-hydroxylase/C17,20-lyase inhibitors

BOCK MARK GARY4 citations70
US8946260B2Feb 3, 2015

17α-hydroxylase/C17,20-lyase inhibitors

BOCK MARK GARY2 citations60
US9339501B2May 17, 2016

17a-hydroxylase/C17,20-lyase inhibitors

BOCK MARK GARY0 citations49

MC ALLISTER ANDRES

1 patent
US8440679B2May 14, 2013

Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors

MC ALLISTER ANDRES53 citations90

BOCK MARK G

1 patent
US8263635B2Sep 11, 2012

Inhibitors of CYP 17

BOCK MARK G17 citations89

NOVARTIS AG

1 patent
USRE45173ESep 30, 2014

Inhibitors of CYP 17

NOVARTIS AG2 citations57

ROCHE DIDIER

1 patent
US8575161B2Nov 5, 2013

Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators

ROCHE DIDIER1 citations42

MC ALLISTER ANDRÈS

1 patent
US8962637B2Feb 24, 2015

Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

MC ALLISTER ANDRÈS1 citations39